Investra-24hs USFDA warning Letter
The United States (U.S.) Food and Drug Administration (FDA) recently reviewed your websites (listed at the bottom of this letter) and determined that they offer products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, the websites listed below offer unapproved new drugs and misbranded drugs for sale in violation of sections 301(a), 301(d), 503(b), and 505(a) of the FD&C Act [21 U.S.C. §§ 331(a), 331(d), 353(b), and 355(a)]. FDA requests that you immediately cease marketing violative drug products to U.S. consumers.
(Notice of Unlawful Sale of Unapproved and Misbranded Drug Products to United States Consumers over the Internet)
For more USFDA warning Letter Visit :http://pharmaguidances.com/shop/guideline/usfda-warning-letter/